CJC-1295 No DAC 10mg | Research Peptide

CJC-1295 NO DAC 10MG RESEARCH PEPTIDE

CJC-1295 No DAC is a synthetic Growth Hormone-Releasing Hormone (GHRH) analog studied in controlled laboratory research for its interaction with GHRH receptors, growth-hormone signaling, pituitary function, and downstream endocrine pathways.

What it is:
CJC-1295 No DAC—often referred to in research contexts as Modified GRF (1-29)—is a modified peptide based on the first 29 amino acids of GHRH. The No DAC form does not contain the Drug Affinity Complex found in longer-acting CJC-1295 variants.

Mechanism & Research Pathways:
Research focuses on its interaction with GHRH receptors and the resulting signaling involved in growth hormone release. It is also investigated in relation to downstream IGF-1 signaling, pituitary biology, endocrine regulation, and cellular signaling.

Research Areas:

• GHRH receptor research
• Growth-hormone signaling
• Pituitary pathway research
• IGF-1 signaling research
• Endocrine biology
• Peptide signaling studies
• Cellular pathway research

Product Details:
Compound: CJC-1295 No DAC
Research Name: Modified GRF (1-29)
Size: 10mg
Form: Research Peptide
Brand: Your Peptide Source

IMPORTANT RESEARCH NOTICE
FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.

This material is intended exclusively for controlled laboratory research. It is not intended for human or veterinary use or to diagnose, treat, cure, or prevent any disease.